Journal of NeuroscienceNeurosciencePeer-reviewed journal article
Modulation of hippocampal network oscillation by PICK1-dependent cell surface expression of mGlu3 receptors
Pola TuduriiD, Nathalie BouquieriD, Benôıt GirardiD, Enora MoutiniD, Maxime Thouaye, Julie PerroyiD, Federica BertasoiD, Jeanne SteriD
Abstract
mGlu3 receptors control the sleep/wake architecture which plays a role in the glutamatergic pathophysiology of schizophrenia. Interestingly, mGlu3 receptors expression is decreased in the brain of schizophrenic patients. However, little is known about the molecular mechanisms regulating mGlu3 receptors at the cell membrane. Subcellular receptor localization is strongly dependent on proteinprotein interactions. Here we show that mGlu3 interacts with PICK1 and that their binding is important for receptor surface expression and function. Disruption of their interaction via an mGlu3 C-terminal mimicking peptide or an inhibitor of the PDZ domain of PICK1 altered the functional expression of mGlu3 receptors. Consequently, we investigated whether disruption of the mGlu3-PICK1 interaction affects hippocampal theta oscillations in vitro and in vivo. We found a decreased frequency of theta oscillations in organotypic hippocampal slices, similar to what previously observed in mGlu3 -/- mice. In addition, hippocampal theta power was reduced during REM sleep, NREM sleep and wake states after intra-ventricular administration of the mGlu3 C-terminal mimicking peptide. Targeting the mGlu3-PICK1 complex could thus be relevant to the pathophysiology of schizophrenia.
- Citations
- 5
- FWCI
- 0.55
- Field percentile
- top 43%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Activating mGlu3 metabotropic glutamate receptors rescues schizophrenia-like cognitive deficits through metaplastic adaptations within the hippocampus.
S. Dogra, B. J. Stansley, … P. J. Conn·bioRxiv·Oct 27, 2020
- An unsuspected physiological role for mGluRIII glutamate receptors in hippocampal area CA1
Maurice A. Petroccione, Marcello Melone, … Annalisa Scimemi·Cell ReportsPeer-reviewed·May 28, 2026
- GSK-3β regulates the synaptic expression of NMDA receptors via phosphorylation of phosphatidylinositol 4 kinase type IIα
Mascia Amici, Yeseul Lee, … Graham L. Collingridge·European Journal of NeurosciencePeer-reviewed·May 28, 2020
- CRISPR/Cas9 mediated intersectional knockout of GSK3β in D2 receptor expressing mPFC neurons reveals contributions to emotional regulation
Jivan Khlghatyan, Jean‐Martin Beaulieu·The CRISPR JournalPeer-reviewed·Jun 1, 2020
- Blockade of Kv3.1 by MK-801, a PCP-Derivative NMDA Receptor Inhibitor: Implications for Models of Schizophrenia
Tae Jun Park, Sang Woong Park, … Young Min Bae·bioRxiv·Sep 13, 2026
- NMDAr BLOCKING BY MK801 ALTERS HIPPOCAMPAL AND PREFRONTAL CORTEX OSCILLATIONS AND IMPAIRS SPATIAL WORKING MEMORY IN MICE.
Pablo Abad-Perez, Francisco Javier Molina Payá, … Jorge R. Brotons‐Mas·bioRxiv·Sep 22, 2021